Medscape:医护人员如何应对职业暴露问题

2014-04-17 MedSci改编 鲁沛的日志

很多医生护士们都有过这样的经历,在为病人看诊或者手术或者打针的时候,由于病人的挣扎或者不配合而误伤到自己的现象,尤其是当病人患有肝炎这样的传染病时,经验不足的人难免有些不知所措。临床上职业暴露是不可避免的,以下小编收集了网上常出现的职业暴露现象,并综合指南和各专家的建议,给出一些应对常见职业暴露的方法。常见职业暴露现象:1、被采过血的针扎到;2、被梅毒患者的针扎到;3、针灸时被丙肝病人的针扎到;4

很多医生护士们都有过这样的经历,在为病人看诊或者手术或者打针的时候,由于病人的挣扎或者不配合而误伤到自己的现象,尤其是当病人患有肝炎这样的传染病时,经验不足的人难免有些不知所措。临床上职业暴露是不可避免的,以下小编收集了网上常出现的职业暴露现象,并综合指南和各专家的建议,给出一些应对常见职业暴露的方法。

常见职业暴露现象:

1、被采过血的针扎到;
2、被梅毒患者的针扎到;
3、针灸时被丙肝病人的针扎到;
4、实验室被小鼠用过的针扎到;
5、被患有肝炎/HIV的患者使用过的针扎到;
6、手术时病人患有大三阳,不小心被柳叶刀伤到;

在Medscape 2013年1月发布的一篇关于医生职业暴露的文章中,对HIV的职业暴露现象做了一些指点,这对其他类型的暴露也有借鉴意义。

首先有几个基本事项:

1.接种疫苗。

医护人员需定期做检查,必要时打加强针。防范于未然。

2.做好防护工作。

手套、口罩、大白挂、实验服······做好防护措施,勿因事小而不为。

3.如不幸中招,如论多小的被感染风险,一定要检查。

4.不管是针扎还是刀划,伤口要用肥皂和水清洗,千万不要挤压!!(挤“毒血”没用,嘴吸更不可以),如果是粘膜暴露(眼睛等)请用大量水冲洗;

接下来,先说最常见的乙肝(这里说的是接触表面抗原阳性的病人,虽然e抗原阳性和e抗原阴性的感染风险不同,但是处理方式是相同的):

1.如果以前没有接种过疫苗也没有表面抗体:1针乙肝免疫球蛋白+第1针乙肝疫苗(剩下的2针疫苗分别在1个月、6个月后补完);

2.如果最近正在打疫苗:1针乙肝免疫球蛋白+把剩下的疫苗补完;

3.如果以前接种过疫苗且表面抗体≥10IU/L:不需任何治疗;

4.如果以前接种过疫苗但表面抗体<10IU/L:1)如果还没有完成第二次的三针疫苗——1针乙肝免疫球蛋白+把剩下的疫苗补完;2)如果已经完整接种过两次三针疫苗还是没有抗体——2针乙肝免疫球蛋白;

5.如果以前接种过疫苗但是不知道自己表面抗体水平:1针疫苗加强针+检测表面抗体水平(注意,同时给加强针,不能因为等抗体检测结果错过了预防时机!)

免疫球蛋白和疫苗都最好在24小时内注射,如果过了14天就不能注射免疫球蛋白了;接种完所有疫苗1-2个月后查一下表面抗体水平

在Medscape的这篇文章里还提到,如果不知道这个人是否有乙肝,而他/她来自乙肝高发地区(比如中国),那你要按他/她是表面抗原阳性来处理,因此,在中国最安全的保护方法还是及时接种疫苗。

然后说丙肝(HCV抗体阳性和/或HCV-RNA阳性),非常悲催的一件事是目前并没有有效的丙肝暴露后预防方法!!除非确诊被感染了,不然免疫球蛋白和抗病毒药物均不推荐使用...

如果暴露了,只能:

在第4周时,查HCV-RNA和肝功能;

在第12周时,查HCV-RNA和肝功能;

在第24周时,查肝功能和HCV抗体...

如果在这期间任何一次转氨酶升高,复查HCV-RNA;一旦HCV-RNA阳性,那么,该怎么治就怎么治吧...

最后是HIV

1.一旦有可疑暴露需立即处理,预防性治疗应在2小时内开始,与此同时评估感染风险等;

2.目前推荐的药物是tenofovir(替诺福韦) + emtricitabine(恩曲他滨)+ raltegravir(雷格特韦);

3.病人和被暴露者都要测HIV-RNA;

4.如果确定需要预防性治疗(不管是否确定都要先开始治,确定不需要了再停),在4周和12周复测HIV,12周HIV还是阴性的话就可以阿弥陀佛了...

引用:

Barry S. Zingman,HIV Prophylaxis Following Occupational Exposure: Guideline and Commentary.Medscape HIV/AIDS January 30, 2013

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (12)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2016-10-11 zybear

    非常不错?

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2016-01-11 medsic

    感谢分享~

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2016-01-11 medsic

    怎么能避免呢,,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2016-01-11 medsic

    怎么能避免呢,,

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2016-01-11 medsic

    了解,

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2016-01-11 medsic

    了解,

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2014-09-14 feather89
  8. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2014-10-03 smlt2008
  9. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=143978, encodeId=77161439e853, content=非常不错?, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210720/81c525def1c4490db2c4d4fd31f4b910/367559b074d146aeab71188669c2396a.jpg, createdBy=3ec21628724, createdName=zybear, createdTime=Tue Oct 11 10:34:44 CST 2016, time=2016-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55930, encodeId=7a60559300b, content=感谢分享~, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:19:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55926, encodeId=a0d75592657, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55927, encodeId=28925592ea3, content=怎么能避免呢,,, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55928, encodeId=eb6c559284c, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=55929, encodeId=463555929a1, content=了解,, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Mon Jan 11 16:18:00 CST 2016, time=2016-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1725590, encodeId=033d1e25590d4, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Sun Sep 14 22:26:00 CST 2014, time=2014-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1897945, encodeId=c08f189e945e2, content=<a href='/topic/show?id=832c404308' target=_blank style='color:#2F92EE;'>#CAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4043, encryptionId=832c404308, topicName=CAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c39f145, createdName=smlt2008, createdTime=Fri Oct 03 07:26:00 CST 2014, time=2014-10-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1278453, encodeId=720e12e845346, content=<a href='/topic/show?id=d80c343e4fd' target=_blank style='color:#2F92EE;'>#医护人员#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34374, encryptionId=d80c343e4fd, topicName=医护人员)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f34c147, createdName=ay2000fy, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1350944, encodeId=2be21350944a7, content=<a href='/topic/show?id=f5a31596056' target=_blank style='color:#2F92EE;'>#SCAP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15960, encryptionId=f5a31596056, topicName=SCAP)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Sat Apr 19 09:26:00 CST 2014, time=2014-04-19, status=1, ipAttribution=)]
    2014-04-19 zhaojie88

相关资讯

安医附二院召开五名医护人员被砍伤亡恶性事件发布会

     11月13日上午,安徽医科大学第二附属医院发生恶性刺医事件,共有5名医护人员被砍伤,其中一名护士长牺牲。   安徽医科大学第二附属医院13日下午3点10分,召开了新闻发布会。事件发生于上午11点左右,持刀男子砍伤了5人,被砍伤的是一名主任医师、一名副主任医生及两名护士(一男一女),泌尿外科戴姓护士长左颈部受伤严重抢救无效死亡。犯罪嫌疑人在逃离时被保安制服,随后被民警控制。发布会现场,

医生怕体检?医护群体成癌症高发人群

“一年一度职工健康体检,头夜,忽然有种读书那些年考试前夜的感觉。迈进体检中心,就像当年走进考场的忐忑。那时怕挂了,现在更怕挂了……”2月9日上午,四川大学华西医院耳鼻喉头颈外科主任医师赵宇(微博@罩得住他爸 )发出这条微博,并很快引起北京协和医院变态反应科主任尹佳(@协和尹佳)的转发评论——“很多医生怕体检”。随后微博继续发酵,诸多医护圈博友纷纷回应: @珊宝的爸爸:你娃运气好,

安医二附院8名医护荣获合肥市见义勇为先进个人

          在“11.13”袭医案件中,安徽医科大学第二附属医(简称安医二附院)院泌尿外科8名医护人员在歹徒行凶过程中无所畏惧,勇敢与歹徒搏斗,阻止了不法分子继续行凶伤人的企图。日前,合肥市政法委正式认定并决定表彰王毅等8位同志的见义勇为行为。   11月22日下午,安医二附院行政四楼会议中心召开了合肥市见义勇为先进个人表彰会,大会对我院王毅等8位医护员工进行隆重表彰。合肥市政法委综

戴光琼同志因公牺牲 获得劳动模范荣誉称号

仅仅两周,你还记得吗?相关事件经过:2012-11-26:高开焰厅长慰问安医二附院受害医护人员 2012-11-26:戴光琼同志因公牺牲 获得劳动模范荣誉称号2012-11-26:安医二附院8名医护荣获合肥市见义勇为先进个人2012-11-26:戴光琼同志遗体告别仪式隆重举行2012-11-22:安医二附院已故护士长戴光琼:丈夫眼中工作狂 2012-11-21:安医大二附院故意杀人案嫌犯被报请批捕

谁来守护我们的白衣天使:医护人员的职业安全问题

每年5月12日是国际护士节,一直以来,医护人员不顾自身的辛苦和安危,奋战在救死扶伤的第一线。而这一神圣职责的背后,医务人员自身的健康和安全问题往往最易被忽略。医务人员的健康安全状况不仅面临来自医院环境中潜在危险因素的挑战,个人防护用品中存在的质量问题如手套、口罩、隔离衣等也会对医护工作者造成威胁。 医护人员安全堪忧 防护措施亟待提升 由于职业的特殊性,医护人员长期处于血源性病原体职业暴露的危险